Clinical Trial Update: Cromoglicate in Mastocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial of Cromoglicate for mastocytosis conducted by LEO Pharma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mastocytosis

Drugs mentioned

• Cromogulate (cromoglicate)

Snippet

Sponsor: LEO Pharma | Conditions: Mastocytosis | Phase 2 | Status: TERMINATED